Stragegic Market Research, Pharmaceuticals, Biotechnology
     
 

Antibacterial Market Research Examples

 
 

New Product Development

New Product Development

International Market Appeal for a New Gram-Negative Antibacterial Agent
International market research with a range of hospital-based physicians key gatekeepers within hospitals informed a go-no go decision on development of a new agent

Preparation for Market Launch:

Preparation for Market Launch

Staph Aureus Vaccine Stocking and Administration Opportunities
Qualitative market research with physicians, financial administrators, pharmacists, and pharmacy & therapeutics (P&T) committee members identified optimal locations and systems for administration and stocking of this novel developmental vaccine for the prevention of post-surgical staph aureus infections   

Global Policy Research on Market Appeal of Follow-On Products
Observant LLC interviewed multiple specialties to ascertain the incremental value of follow-on products over first-in-class products, particularly in the treatment of pneumonia and HIV

Post-Launch Marketing Issues:

Post-Launch Marketing Issues

Potential International Marketing Impact of Phase IV Antibacterial Clinical Trials
Observant LLC interviewed specialists in the US, EU and Asia to evaluate a Phase IV trial. Led to strategies to leverage each result scenario to the product’s advantage

International Competitive Antibiotic Product Assessments and Counter-Positioning  
Four phases of antibacterial wargaming market research was conducted to assess the potential impact, benefits, and drawbacks of several new MRSA agents in development. This research was used to develop counter-strategies for the client’s own products.

Product Lifecycle Management:

Product Lifecycle Management

Product Extension Materials for Patient Communication
To prepare for market launch of a novel formulation of an antibiotic, Observant LLC researchers interviewed patients to assess materials explaining the administration process.  Informed refinement of materials to reduce patients’ intent to call physicians during normal symptom progression


Return to Main Infectious Disease Page
Observant LLC | 1601 Trapelo Road, Suite 255 | Waltham, MA 02451 | 781.642.0644 | info@observant.biz
HOME | RESEARCH EXPERTISE | THERAPEUTIC EXPERTISE | INNOVATIONS | MEDIA AND CASES | LEADERSHIP | CAREERS | CONTACT
Observant Home